West Pharmaceutical Services, Inc. insider trading
WSTfinancial statementsForm 4 filings on EDGAR85 transactions since Nov 1, 2024
From August 4, 2026 to November 1, 2026, 0 insiders at West Pharmaceutical Services, Inc. bought $0 of stock in the open market, and 1 sold $5M. Officers and directors accounted for $0 of purchases and $5M of sales. The last reported transaction was an option exercise by Favorite Annette F on September 15, 2026.
The answer card and chart use the same period. Change the range above the chart to update both. Form 4 filings through September 15, 2026; awards, option exercises, tax withholding and gifts are excluded from these totals.
Stock price and insider activity
Daily price candles with insider purchases and sales directly beneath them on the same timeline. Bars show individual days; totals sum all days in the selected period.
Bought $0Sold $5MAug 4, 2026 – Nov 1, 2026
purchases above zero; sales below. Both use the transaction date and the same dollar scale. Hover, tap, or use arrow keys to inspect a date. Awards, exercises, tax withholding and gifts are excluded.
Dates with prices or insider activity are spaced evenly; empty weekends and holidays are omitted. Prices through Oct 30, 2026. Insider data through Nov 1, 2026. Prices are adjusted for splits; transaction values are reported dollars.
Every transaction
85 transactions from November 1, 2024 to November 1, 2026, newest first. Open-market purchases and sales are coloured; awards, exercises, tax withholding and gifts are grey and not counted.
| Traded | Insider | Role | Transaction | Shares | Price | Value | Held after | Filed |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | Favorite Annette F | Sr. VP & Chief HR Officer | option exercise | 2,524 | $89.64 | $226K | 24,342 | Sep 15, 2026 |
| Sep 15, 2026 | Favorite Annette F | Sr. VP & Chief HR Officer | open-market sale10b5-1 | 2,524 | $365.00 | $921K | 21,818 | Sep 15, 2026 |
| Sep 14, 2026 | Favorite Annette F | Sr. VP & Chief HR Officer | option exercise | 2,500 | $89.64 | $224K | 24,318 | Sep 15, 2026 |
| Sep 14, 2026 | Favorite Annette F | Sr. VP & Chief HR Officer | open-market sale10b5-1 | 2,500 | $355.00 | $888K | 21,818 | Sep 15, 2026 |
| Sep 11, 2026 | Favorite Annette F | Sr. VP & Chief HR Officer | option exercise | 2,500 | $89.64 | $224K | 24,318 | Sep 15, 2026 |
| Sep 11, 2026 | Favorite Annette F | Sr. VP & Chief HR Officer | open-market sale10b5-1 | 2,500 | $345.00 | $863K | 21,818 | Sep 15, 2026 |
| Sep 8, 2026 | Favorite Annette F | Sr. VP & Chief HR Officer | option exercise | 2,817 | $83.47 | $235K | 19,662 | Sep 10, 2026 |
| Sep 8, 2026 | Favorite Annette F | Sr. VP & Chief HR Officer | open-market sale | 2,817 | $340.81 | $960K | 16,845 | Sep 10, 2026 |
| Sep 8, 2026 | Favorite Annette F | Sr. VP & Chief HR Officer | option exercise | 2,818 | $83.47 | $235K | 19,663 | Sep 10, 2026 |
| Sep 8, 2026 | Favorite Annette F | Sr. VP & Chief HR Officer | open-market sale | 2,818 | $340.81 | $960K | 16,845 | Sep 10, 2026 |
| Sep 8, 2026 | Favorite Annette F | Sr. VP & Chief HR Officer | option exercise | 2,500 | $89.64 | $224K | 19,345 | Sep 10, 2026 |
| Sep 8, 2026 | Favorite Annette F | Sr. VP & Chief HR Officer | open-market sale | 2,500 | $340.81 | $852K | 16,845 | Sep 10, 2026 |
| Aug 11, 2026 | McMahon Robert W. | SVP & Chief Financial Officer | option exercise | 794 | — | — | 3,775 | Aug 12, 2026 |
| Aug 11, 2026 | McMahon Robert W. | SVP & Chief Financial Officer | tax withholding | 346 | $351.37 | $121K | 3,429 | Aug 12, 2026 |
| Aug 11, 2026 | McMahon Robert W. | SVP & Chief Financial Officer | option exercise | 6,355 | — | — | 9,784 | Aug 12, 2026 |
| Aug 11, 2026 | McMahon Robert W. | SVP & Chief Financial Officer | tax withholding | 2,764 | $351.37 | $971K | 7,021 | Aug 12, 2026 |
| May 12, 2026 | Campbell Shane Alden | SVP, Proprietary Segment | option exercise | 296 | — | — | 358 | May 14, 2026 |
| May 12, 2026 | Campbell Shane Alden | SVP, Proprietary Segment | tax withholding | 84 | $312.07 | $26K | 274 | May 14, 2026 |
| May 12, 2026 | Campbell Shane Alden | SVP, Proprietary Segment | option exercise | 474 | — | — | 748 | May 14, 2026 |
| May 12, 2026 | Campbell Shane Alden | SVP, Proprietary Segment | tax withholding | 135 | $312.07 | $42K | 613 | May 14, 2026 |
| May 4, 2026 | Pucci Paolo | Director | award | 791 | $0.00 | — | 11,854 | May 6, 2026 |
| May 4, 2026 | Michels Douglas A | Director | award | 791 | $0.00 | — | 46,496 | May 6, 2026 |
| May 4, 2026 | Lockhart Stephen H | Director | award | 791 | $0.00 | — | 3,523 | May 6, 2026 |
| May 4, 2026 | Lai Goldman Myla | Director | award | 791 | $0.00 | — | 20,435 | May 6, 2026 |
| May 4, 2026 | Keller Deborah L | Director | award | 791 | $0.00 | — | 11,560 | May 6, 2026 |
| May 4, 2026 | Joseph Molly | Director | award | 791 | $0.00 | — | 4,398 | May 6, 2026 |
| May 4, 2026 | Haugen Janet Brutschea | Director | award | 791 | $0.00 | — | 2,373 | May 6, 2026 |
| May 4, 2026 | Friel Robert F | Director | award | 791 | $0.00 | — | 5,513 | May 6, 2026 |
| May 4, 2026 | Feehery William F | Director | award | 791 | $0.00 | — | 32,519 | May 6, 2026 |
| May 4, 2026 | Buthman Mark A | Director | award | 791 | $0.00 | — | 44,309 | May 6, 2026 |
| Apr 27, 2026 | Favorite Annette F | Sr. VP & Chief HR Officer | option exercise | 2,817 | $83.47 | $235K | 19,645 | Apr 29, 2026 |
| Apr 27, 2026 | Favorite Annette F | Sr. VP & Chief HR Officer | open-market sale | 2,817 | $305.20 | $860K | 16,828 | Apr 29, 2026 |
| Apr 27, 2026 | Winters Chad | VP, Chief Accounting Officer | option exercise | 896 | $173.22 | $155K | 2,419 | Apr 29, 2026 |
| Apr 27, 2026 | Winters Chad | VP, Chief Accounting Officer | open-market sale | 896 | $300.67 | $269K | 1,523 | Apr 29, 2026 |
| Feb 20, 2026 | Poussot Rodolphe Jean | SVP, Strategy & Corporate Dev | tax withholding | 130 | $241.12 | $31K | 561 | Feb 23, 2026 |
| Feb 20, 2026 | Poussot Rodolphe Jean | SVP, Strategy & Corporate Dev | option exercise | 383 | — | — | 691 | Feb 23, 2026 |
| Feb 20, 2026 | Witherspoon Charles | VP & Treasurer | tax withholding | 22 | $241.12 | $5K | 1,408 | Feb 23, 2026 |
| Feb 20, 2026 | Witherspoon Charles | VP & Treasurer | option exercise | 60 | — | — | 1,430 | Feb 23, 2026 |
| Feb 20, 2026 | Winters Chad | VP, Chief Accounting Officer | option exercise | 89 | — | — | 1,553 | Feb 23, 2026 |
| Feb 20, 2026 | Winters Chad | VP, Chief Accounting Officer | tax withholding | 30 | $241.12 | $7K | 1,523 | Feb 23, 2026 |
| Feb 18, 2026 | Poussot Rodolphe Jean | SVP, Strategy & Corporate Dev | tax withholding | 28 | $248.26 | $7K | 307 | Feb 19, 2026 |
| Feb 18, 2026 | Poussot Rodolphe Jean | SVP, Strategy & Corporate Dev | option exercise | 82 | — | — | 335 | Feb 19, 2026 |
| Feb 18, 2026 | Green Eric Mark | President, CEO and Board Chair, Director | option exercise | 1,319 | — | — | 175,734 | Feb 19, 2026 |
| Feb 18, 2026 | Green Eric Mark | President, CEO and Board Chair, Director | tax withholding | 574 | $248.26 | $142K | 175,161 | Feb 19, 2026 |
| Feb 18, 2026 | Favorite Annette F | Sr. VP & Chief HR Officer | option exercise | 135 | — | — | 17,410 | Feb 19, 2026 |
| Feb 18, 2026 | Favorite Annette F | Sr. VP & Chief HR Officer | tax withholding | 36 | $248.26 | $9K | 17,374 | Feb 19, 2026 |
| Feb 17, 2026 | Witherspoon Charles | VP & Treasurer | tax withholding | 42 | $243.19 | $10K | 1,370 | Feb 19, 2026 |
| Feb 17, 2026 | Witherspoon Charles | VP & Treasurer | award | 116 | $0.00 | — | 1,411 | Feb 19, 2026 |
| Feb 17, 2026 | Winters Chad | VP, Chief Accounting Officer | award | 150 | $0.00 | — | 1,513 | Feb 19, 2026 |
| Feb 17, 2026 | Winters Chad | VP, Chief Accounting Officer | tax withholding | 51 | $243.19 | $12K | 1,462 | Feb 19, 2026 |
Who the insiders are
Everyone who reported a transaction since November 1, 2024, by open-market value over twelve months. Shares held are after the insider’s latest directly held transaction.
| Insider | Role | Last transaction | Kind | Shares held | Bought, 12 months | Sold, 12 months | Sales under a plan |
|---|---|---|---|---|---|---|---|
| Favorite Annette F | Sr. VP & Chief HR Officer | Sep 15, 2026 | option exercise | 24,342 | — | $6M (7) | 3 of 7 |
| Winters Chad | VP, Chief Accounting Officer | Apr 27, 2026 | option exercise | 2,419 | — | $269K (1) | 0 of 1 |
| McMahon Robert W. | SVP & Chief Financial Officer | Aug 11, 2026 | option exercise | 3,775 | — | — | — |
| Witherspoon Charles | VP & Treasurer | Feb 20, 2026 | tax withholding | 1,408 | — | — | — |
| Green Eric Mark | President, CEO and Board Chair, Director | Feb 18, 2026 | option exercise | 175,734 | — | — | — |
| Campbell Shane Alden | SVP, Proprietary Segment | May 12, 2026 | option exercise | 358 | — | — | — |
| Haugen Janet Brutschea | Director | May 4, 2026 | award | 2,373 | — | — | — |
| Poussot Rodolphe Jean | SVP, Strategy & Corporate Dev | Feb 20, 2026 | tax withholding | 561 | — | — | — |
| Birkett Bernard | Sr VP, Chief Financial Officer | Feb 18, 2025 | tax withholding | 7,520 | — | — | — |
| Pucci Paolo | Director | May 4, 2026 | award | 11,854 | — | — | — |
| Michels Douglas A | Director | May 4, 2026 | award | 46,496 | — | — | — |
| Lockhart Stephen H | Director | May 4, 2026 | award | 3,523 | — | — | — |
| Lai Goldman Myla | Director | May 4, 2026 | award | 20,435 | — | — | — |
| Keller Deborah L | Director | May 4, 2026 | award | 11,560 | — | — | — |
| Joseph Molly | Director | May 4, 2026 | award | 4,398 | — | — | — |
| Friel Robert F | Director | May 4, 2026 | award | 5,513 | — | — | — |
| Feehery William F | Director | May 4, 2026 | award | 32,519 | — | — | — |
| Buthman Mark A | Director | May 4, 2026 | award | 44,309 | — | — | — |
| Reiss-Clark Cindy | Chief Commercial Officer | Feb 18, 2025 | tax withholding | 5,047 | — | — | — |
| MacKay Kimberly Banks | SVP, GC & Corporate Secretary | Feb 18, 2025 | tax withholding | 1,512 | — | — | — |
| Hofmann Thomas W | Director | May 6, 2025 | award | 44,637 | — | — | — |
Questions
Are West Pharmaceutical Services, Inc. insiders buying or selling?
Over the twelve months to November 1, 2026, 2 insiders at West Pharmaceutical Services, Inc. sold $7M of stock in the open market, all by officers and directors, and no insider bought. Net, insiders sold $7M. Only open-market purchases and sales are counted.
Who sold the most West Pharmaceutical Services, Inc. stock in the last year?
Favorite Annette F (Sr. VP & Chief HR Officer) sold $6M in 7 open-market sales over the twelve months to November 1, 2026.
Do West Pharmaceutical Services, Inc. executives sell under 10b5-1 plans?
3 of the 8 open-market sales in the last twelve months (38%) were reported as made under a Rule 10b5-1 trading plan, set up in advance. A sale under a plan is still counted as a sale.
What counts as insider buying here?
Only open-market purchases (Form 4 code P) and sales (code S) by officers, directors and 10% owners. Stock awards, option exercises, shares withheld for tax and gifts are listed in the table but never counted as buying or selling.
More on West Pharmaceutical Services, Inc.
- West Pharmaceutical Services, Inc. financial statements
- 2 tracked funds holding WST
- Insider buying and selling across all companies
- These transactions as JSON
From Form 4, 4/A and 5 filings with the SEC. A record of insider transactions, not a recommendation.